NCT05312398

CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: ACTIVE_NOT_RECRUITING

Phase: PHASE2

Sponsor: University of Campania Luigi Vanvitelli

Condition: Metastatic Colorectal Adenocarcinoma

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: stale_update_signal | long_recruitment_duration_signal

Results signal: Low Signal

Operational burden: large_enrollment_target_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.